February 2018

Diagnostic Patents After Sequenom

By: Gideon B. Eckhouse  |   February 22, 2018

The discovery of cell-free fetal DNA (cffDNA) was a groundbreaking and innovative discovery that has formed the basis for a number of patent filings. In the recent patent dispute between Illumina and Ariosa Diagnostics, we can compare patent claims that were found valid and infringed to those that were found not eligible under the seminal CAFC case of Ariosa Diagnostics v. Sequenom.